Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.4 USD | +1.29% | +1.13% | +14.23% |
May. 08 | Transcript : U.S. Physical Therapy, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 07 | Earnings Flash (USPH) U.S. PHYSICAL THERAPY Reports Q1 EPS $0.46, vs. Street Est of $0.56 | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 37.93 times its estimated earnings per share for the ongoing year.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.23% | 1.6B | C+ | ||
-18.90% | 16.51B | B+ | ||
+4.50% | 12.53B | B | ||
+4.81% | 11.74B | B+ | ||
+2.43% | 10.06B | B+ | ||
+29.69% | 8.71B | B | ||
-4.75% | 7.57B | A- | ||
+19.68% | 7.22B | D | ||
+5.46% | 6.68B | B- | ||
-2.79% | 4.32B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- USPH Stock
- Ratings U.S. Physical Therapy, Inc.